Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Share-based Compensation (2016 - 2025)

cbdMD's Share-based Compensation history spans 10 years, with the latest figure at $2505.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 96.95% year-over-year to $2505.0; the TTM value through Dec 2025 reached $6912.0, down 92.66%, while the annual FY2025 figure was $86657.0, 629.13% up from the prior year.
  • Share-based Compensation for Q4 2025 was $2505.0 at cbdMD, down from $4407.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.4 million in Q1 2023 and bottomed at -$1.3 million in Q2 2023.
  • The 5-year median for Share-based Compensation is $82250.0 (2024), against an average of $184306.2.
  • The largest annual shift saw Share-based Compensation soared 1315.4% in 2021 before it tumbled 412.95% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $505466.0 in 2021, then tumbled by 91.4% to $43449.0 in 2022, then surged by 136.57% to $102787.0 in 2023, then fell by 19.98% to $82250.0 in 2024, then crashed by 96.95% to $2505.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Share-based Compensation are $2505.0 (Q4 2025), $4407.0 (Q3 2025), and $82250.0 (Q4 2024).